Literature DB >> 8394044

Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.

H Fujiki1, M Suganuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8394044     DOI： 10.1016/s0065-230x(08)60958-6

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  56 in total

1.  PKR regulates B56(alpha)-mediated BCL2 phosphatase activity in acute lymphoblastic leukemia-derived REH cells.

Authors:  Vivian R Ruvolo; Svitlana M Kurinna; Kul B Karanjeet; Todd F Schuster; Alberto M Martelli; James A McCubrey; Peter P Ruvolo
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

2.  Regulation of natural killer cell-mediated cytotoxicity by serine/threonine phosphatases: identification of a calyculin A-sensitive serine/threonine kinase.

Authors:  A Bajpai; Z Brahmi
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

3.  Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth.

Authors:  Jaya Sangodkar; Abbey Perl; Rita Tohme; Janna Kiselar; David B Kastrinsky; Nilesh Zaware; Sudeh Izadmehr; Sahar Mazhar; Danica D Wiredja; Caitlin M O'Connor; Divya Hoon; Neil S Dhawan; Daniela Schlatzer; Shen Yao; Daniel Leonard; Alain C Borczuk; Giridharan Gokulrangan; Lifu Wang; Elena Svenson; Caroline C Farrington; Eric Yuan; Rita A Avelar; Agnes Stachnik; Blake Smith; Vickram Gidwani; Heather M Giannini; Daniel McQuaid; Kimberly McClinch; Zhizhi Wang; Alice C Levine; Rosalie C Sears; Edward Y Chen; Qiaonan Duan; Manish Datt; Shozeb Haider; Avi Ma'ayan; Analisa DiFeo; Neelesh Sharma; Matthew D Galsky; David L Brautigan; Yiannis A Ioannou; Wenqing Xu; Mark R Chance; Michael Ohlmeyer; Goutham Narla
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

4.  Using generalized additive models to investigate factors influencing cyanobacterial abundance through phycocyanin fluorescence in East Lake, China.

Authors:  Yi-Ming Kuo; Jun Yang; Wen-Wen Liu; Enmin Zhao; Ran Li; Liquan Yao
Journal:  Environ Monit Assess       Date:  2018-09-20       Impact factor: 2.513

5.  Valproic acid regulates Ang II-induced pericyte-myofibroblast trans-differentiation via MAPK/ERK pathway.

Authors:  Yan Zhang; Feng Gao; Yuan Tang; Jinwen Xiao; Chuanchuan Li; Yu Ouyang; Yuemei Hou
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

6.  Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein.

Authors:  A Takai; K Sasaki; H Nagai; G Mieskes; M Isobe; K Isono; T Yasumoto
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

7.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

Authors:  Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Gerald W Hart; Cheng-Xin Gong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

Review 8.  Targets and effects of yessotoxin, okadaic acid and palytoxin: a differential review.

Authors:  Antonella Franchini; Davide Malagoli; Enzo Ottaviani
Journal:  Mar Drugs       Date:  2010-03-16       Impact factor: 5.118

9.  Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.

Authors:  M Suganuma; S Okabe; E Sueoka; R Nishiwaki; A Komori; N Uda; K Isono; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice.

Authors:  Anne Beghin; Stéphane Belin; Rouba Hage-Sleiman; Rouba Hage Sleiman; Stéphanie Brunet Manquat; Sophie Goddard; Eric Tabone; Lars P Jordheim; Isabelle Treilleux; Marie-France Poupon; Jean-Jacques Diaz; Charles Dumontet
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.